Is CVS Health Corp. (CVS) a Buy, Sell, or Hold?
CVS Health Corp.
NYSE:CVS
$106.18 USD
$0.28 (0.26%)
- Volume
- 11.4M
- Average Volume
- 8.25M
- Market Capitalization
- $135.48B
- P/E Ratio
- 45.97
- Dividend Yield
- 2.51%
- Price Target
- $108.00
- Year High
- $106.90
- Year Low
- $58.50
- Day High
- —
- Day Low
- —
- Payout Ratio
- $1.16
- Current Ratio
- $0.87
Industry, Sector & symbol
| Stock Exchange | NYSE |
| CEO | J. David Joyner |
| Industry | Medical - Healthcare Plans |
| Sector | Healthcare |
| Current Symbol | CVS |
| CUSIP | 126650100 |
| CIK | 0000064803 |
| Web | https://www.cvshealth.com |
| Phone | 401-765-1500 |
| Currency | USD |
| Employees | 300000 |
| Country | US |
Liquidity
| Debt-to-Equity Ratio | 1.01 |
| Payout Ratio | 1.16 |
| Current Ratio | 0.87 |
| Quick Ratio | 0.66 |
| Cash Ratio | 0.11 |
Sales & Book Value
| Annual Sales | $402.07B |
| Price / Sales | 0.33 |
| Cash Flow | 5.81 |
| Price / Cash Flow | 18.32 |
| Price / Book | 1.75 |
Price Target and Rating
| Average Stock Price Forecast | $108.00 |
| High Stock Price Forecast | $123.00 |
| Low Stock Price Forecast | $90.00 |
| Forecast Upside/Downside | -1.69% |
| Consensus Rating | Neutral |
| Rating Score(0-5) | 3 |
| Research Coverage | 41 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $1.39 |
| Trailing P/E Ratio | 45.97 |
| PEG Ratio | -1.02 |
| P/E Growth | -1.02 |
| Net Income | $1.77B |
| Net Margin | 0.72% |
| Pretax Margin | 0.85% |
| Return on Equity | 3.87% |
| Return on Assets | 1.16% |
Financials Score
| AltmanZ Score | 2.46 |
| Piotroski Score | 7.00 |
| Working Capital | -11.59B |
| Total Assets | 252.97B |
| Ebit | 6.56B |
| Market Cap | 135.01B |
| Total Liabilities | 175.34B |
Poll Results
About CVS Health Corp. (NYSE:CVS) Stock
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI. ...
2026-07-14 15:05:00
WOONSOCKET, R.I., July 14, 2026 /PRNewswire/ -- CVS Caremark today announced a global settlement with the Federal Trade Commission (FTC) which further advances the company's leadership in delivering greater affordability for prescription drugs.
CVS settles with FTC, agrees to count TrumpRx drug purchases towards insurance
2026-07-14 14:23:12
CVS Health's Caremark has finalized a settlement with the U.S. Federal Trade Commission in which it agreed to curb use of after-market discounts known as rebates and count consumers' TrumpRx purchases toward their deductibles, an FTC spokesperson said on Tuesday.
Why CVS Health (CVS) is a Top Value Stock for the Long-Term
2026-07-14 10:40:28
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
2 Recession-Resistant Dividend Stocks to Buy and Hold
2026-07-10 12:00:00
You don't need to predict a recession to prepare your portfolio. These two stocks can help.
CVS Health declares quarterly dividend
2026-07-10 10:00:00
CVS Health declares quarterly dividend PR Newswire WOONSOCKET, R.I., July 10, 2026
CVS Health declares quarterly dividend
2026-07-10 09:48:00
WOONSOCKET, R.I., July 10, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents) per share on the Common Stock of the Corporation.
CVS Health (CVS) Stock Declines While Market Improves: Some Information for Investors
2026-07-09 18:46:14
In the closing of the recent trading day, CVS Health (CVS) stood at $102.81, denoting a -1.59% move from the preceding trading day.
2026-07-09 14:34:21
Jim Cramer used his July 9, 2026 CNBC Stop Trading segment to plant a flag on managed care, framing CVS Health (NYSE:CVS | CVS Price Prediction) as the consolidation winner in a sector where insurers are finally getting paid for the risks they underwrite.
Frequently Asked Questions
-
What is the current CVS Health Corp. (CVS) stock price?
-
CVS Health Corp.(NYSE:CVS) stock price is $106.18 in the last trading session. During the trading session, CVS stock reached the peak price of $106.9 while $58.5 was the lowest point it dropped to. The percentage change in CVS stock occurred in the recent session was 0.26% while the dollar amount for the price change in CVS stock was $0.28.
-
CVS's industry and sector of operation?
-
The NYSE listed CVS is part of Medical - Healthcare Plans industry that operates in the broader Healthcare sector.
-
Who are the executives of CVS?
-
David A. Falkowski | Executive Vice President & Chief Compliance Officer
Gustavo A. Giraldo | Head of Markets of Healthcare Benefits
James David Clark | Senior Vice President, Controller & Chief Accounting Officer
Prem S. Shah | Executive Vice President & Group President
J. David Joyner CEBS | CEO, President & Chairman -
How many employees does CVS have?
-
Number of CVS employees currently stands at 300000. CVS operates from One CVS Drive, Woonsocket, RI 02895, US.
-
Link for CVS official website?
-
Official Website of CVS is: https://www.cvshealth.com
-
How do I contact CVS?
-
CVS could be contacted at phone #401-765-1500 and can also be accessed through its website. CVS operates from One CVS Drive, Woonsocket, RI 02895, US.
-
How many shares of CVS are traded daily?
-
The average number of CVS shares traded daily for last 3 months was 8.25M.
-
What is the market cap of CVS currently?
-
The market value of CVS currently stands at $135.48B with its latest stock price at $106.18